Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment
- 1 June 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 75 (9) , 1237-1248
Abstract
To develop a system to estimate the risk of herb-drug interactions that includes the available evidence from clinical and laboratory studies, transparently delineates the algorithm for the risk estimation, could be used in practice settings and allows for adaptation and update.Keywords
Funding Information
- Deutsche Krebshilfe (110150)
This publication has 40 references indexed in Scilit:
- How Many Cancer Patients Use Complementary and Alternative MedicineIntegrative Cancer Therapies, 2011
- Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health studyBMC Complementary and Alternative Medicine, 2011
- The use of herbal medicines by people with cancer: a cross-sectional surveyBritish Journal of Cancer, 2011
- An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx projectSupportive Care in Cancer, 2009
- The Effect of Silymarin on Oral Nifedipine PharmacokineticsPlanta Medica, 2007
- Clinical risk management of herb–drug interactionsBritish Journal of Clinical Pharmacology, 2006
- Clinical Relevance of Drug-Drug InteractionsDrug Safety, 2005
- Potential of chemotherapy?herb interactions in adult cancer patientsSupportive Care in Cancer, 2004
- Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician?Patient Education and Counseling, 2004
- Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activitiesPhytotherapy Research, 2002